Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Valvular Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 229 articles: HTML format

Single Articles

November 2025
1. CAO J, Shen F, Lu F
   Tricuspid valve replacement with a LuX-Valve for tricuspid stenosis via a right atrium access.
   Eur Heart J. 2025 Nov 28:ehaf972. doi: 10.1093.
   PubMed    
   
   
   
2. ZHOU Y, Shang X, Zhong Y
   One-stop percutaneous intervention for severe aortic regurgitation and perivalvular abscess perforation caused by destructive infective endocarditis after David procedure.
   Eur Heart J. 2025 Nov 28:ehaf971. doi: 10.1093.
   PubMed    
   
   
   
3. CHEN X, Jilaihawi H, Wang Y
   One-stop pulmonary artery denervation and transcatheter tricuspid annuloplasty in combined pre- and post-capillary pulmonary hypertension with severe tricuspid regurgitation.
   Eur Heart J. 2025 Nov 28:ehaf934. doi: 10.1093.
   PubMed    
   
   
   
4. CHO SH, Won KY, Kim DH
   AA amyloidosis with clinically overt cardiac involvement confirmed by amyloid A deposition in aortic valve fibroelastoma.
   Eur Heart J. 2025 Nov 28:ehaf894. doi: 10.1093.
   PubMed    
   
   
   
5. CREA F
   Hot topics in valvular heart disease and dyslipedaemias.
   Eur Heart J. 2025;46:4623-4627.
   PubMed    
   
   
   
6. YOGESWARAN V, Otto CM
   Clinical management of moderate mixed aortic valve disease.
   Eur Heart J. 2025 Nov 5:ehaf790. doi: 10.1093.
   PubMed    
   
   
   October 2025
7. MARON MS, Gimeno JR, Veselka J, Barriales-Villa R, et al
   Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.
   Eur Heart J. 2025;46:4076-4086.
   PubMed     Abstract available
   
   
   
8. BAKA T, Moore J, Qin F, Yurista SR, et al
   Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model.
   Eur Heart J. 2025;46:4105-4119.
   PubMed     Abstract available
   
   
   
9. LONG Y, Zhou D, Pan W
   Killing three birds with one stone: transcatheter salvage of aorto-atrial fistula and paravalvular leaks following transcatheter tricuspid valve replacement.
   Eur Heart J. 2025 Oct 17:ehaf796. doi: 10.1093.
   PubMed    
   
   
   
10. LOPEZ SANTI P, Bernard J, Chua A, Laenens D, et al
    Outcomes of moderate mixed aortic valve stenosis and regurgitation.
    Eur Heart J. 2025 Oct 17:ehaf791. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. MCDONAUGH B, Redwood S, Patterson T
    Transcatheter edge-to-edge repair for atrial functional mitral regurgitation: the final frontier.
    Eur Heart J. 2025 Oct 17:ehaf792. doi: 10.1093.
    PubMed    
    
    
    
12. WANG Y, Jin J, Yu S
    Transcatheter aortic valve replacement in unicuspid aortic stenosis: revealed by multimodal imaging.
    Eur Heart J. 2025 Oct 15:ehaf817. doi: 10.1093.
    PubMed    
    
    
    
13. ORR C, Praz F, Kirk BH
    Enhanced education to improve aortic stenosis patient pathways: the AortiCare programme.
    Eur Heart J. 2025 Oct 15:ehaf622. doi: 10.1093.
    PubMed    
    
    
    
14. GORI T, Treede H
    Equal tools, unequal tolls: should sex influence decision-making for aortic valve stenosis?
    Eur Heart J. 2025 Oct 9:ehaf762. doi: 10.1093.
    PubMed    
    
    
    September 2025
15. ARMOUNDAS AA
    The electrocardiogram reimagined: AI-ECG as a prognostic beacon for valvular heart disease.
    Eur Heart J. 2025 Sep 5:ehaf584. doi: 10.1093.
    PubMed    
    
    
    
16. CUDDY SAM
    Aortic stenosis: need for treatment of co-existent cardiac amyloidosis?
    Eur Heart J. 2025 Sep 5:ehaf558. doi: 10.1093.
    PubMed    
    
    
    
17. BLEIZIFFER S, Leuschner F, Rudolph TK, Vonthein R, et al
    Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial.
    Eur Heart J. 2025 Sep 3:ehaf519. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
19. LURZ P, Hahn RT, Kodali S, Makkar R, et al
    Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
    Eur Heart J. 2025 Aug 29:ehaf676. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. PRAZ F, Borger MA, Lanz J, Marin-Cuartas M, et al
    2025 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2025 Aug 29:ehaf194. doi: 10.1093.
    PubMed    
    
    
    
21. MAURIZI N, Monda E, Biagini E, Field E, et al
    Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.
    Eur Heart J. 2025;46:3082-3094.
    PubMed     Abstract available
    
    
    
22. BUTERA G, Montanaro C, Maisano F
    Multiple clips for transcatheter mitral valve repair in failing Fontan.
    Eur Heart J. 2025 Aug 12:ehaf469. doi: 10.1093.
    PubMed    
    
    
    
23. ADAMO M, Pagnesi M, Ajmone Marsan N, Bauersachs J, et al
    Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach.
    Eur Heart J. 2025 Aug 1:ehaf480. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
24. WATANABE A, Hiruma Y, Asanuma T
    Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf539. doi: 10.1093.
    PubMed    
    
    
    
25. NITSCHE C, Ristl R, Treibel TA
    Avoiding immortal time bias for cardiac transthyretin treatment in aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf542. doi: 10.1093.
    PubMed    
    
    
    
26. LI Y, Wei L, Zhang C
    Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients.
    Eur Heart J. 2025 Jul 25:ehaf536. doi: 10.1093.
    PubMed    
    
    
    
27. CREA F
    Challenges in antithrombotic treatment and in the management of valvular heart disease.
    Eur Heart J. 2025;46:2717-2721.
    PubMed    
    
    
    
28. LIANG Y, Sau A, Zeidaabadi B, Barker J, et al
    Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study.
    Eur Heart J. 2025 Jul 16:ehaf448. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. ALHAKAK A, Butt JH, Havers-Borgersen E, Ostergaard L, et al
    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
    Eur Heart J. 2025 Jul 11:ehaf342. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. GIACOPPO D
    Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.
    Eur Heart J. 2025 Jul 11:ehaf099. doi: 10.1093.
    PubMed    
    
    
    
31. KANEKO T, Kagiyama N, Okazaki S, Amano M, et al
    Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2025 Jul 9:ehaf511. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. LIU H, Fang Y, Cheng W
    Traumatic interventricular septal dissection in a bicuspid aortic valve patient: a rare extension into the left ventricle.
    Eur Heart J. 2025 Jul 4:ehaf499. doi: 10.1093.
    PubMed    
    
    
    
33. BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al
    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.
    Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
34. KARTHIKEYAN G, Rajashekar P, Devasenapathy N, Biswas S, et al
    Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial.
    Eur Heart J. 2025 Jun 27:ehaf391. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. YANG WL, Hu BY
    Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation associated with familial thoracic aortic aneurysm type 10.
    Eur Heart J. 2025 Jun 24:ehaf402. doi: 10.1093.
    PubMed    
    
    
    
36. CREA F
    Focus on juvenile hypertension, deep learning-qualified body composition for risk stratification, infective endocarditis, and mixed valvular heart disease.
    Eur Heart J. 2025;46:2249-2252.
    PubMed    
    
    
    
37. COMPAGNONE M, Windecker S, Dall'Ara G, Galvani M, et al
    Great debate: Transcatheter aortic valve implantation should also be performed in non-surgical centres.
    Eur Heart J. 2025 Jun 5:ehaf363. doi: 10.1093.
    PubMed    
    
    
    
38. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
    Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
39. BASU J, Nikoletou D, Miles C, MacLachlan H, et al
    High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.
    Eur Heart J. 2025;46:1803-1815.
    PubMed     Abstract available
    
    
    
40. ISHIKAWA E, Kageyama S
    Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral regurgitation.
    Eur Heart J. 2025 May 13:ehaf334. doi: 10.1093.
    PubMed    
    
    
    
41. BARBANTI M, Costa G, Windecker S, Maisano F, et al
    Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation.
    Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. PEDICINO D, Liuzzo G
    Weekly Journal Scan: does dapagliflozin expand the therapeutic options after transcatheter aortic valve implantation?
    Eur Heart J. 2025 May 6:ehaf309. doi: 10.1093.
    PubMed    
    
    
    
43. LIN S, Zhang H, Li Z
    Quadricuspid aortic valve with partial left coronary sinus isolation.
    Eur Heart J. 2025 May 2:ehaf252. doi: 10.1093.
    PubMed    
    
    
    April 2025
44. VAN KAMPEN A, Levine RA, Borger MA
    Is mitral annular disjunction the cause of arrhythmogenic mitral valve prolapse?
    Eur Heart J. 2025 Apr 24:ehaf264. doi: 10.1093.
    PubMed    
    
    
    
45. COISNE A, Lancellotti P, Cote N, Ternacle J, et al
    Blood biomarkers in left-sided valvular heart disease.
    Eur Heart J. 2025 Apr 22:ehaf232. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. ZITO F, Rhellab R, de Keijzer AR
    Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
    Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
    PubMed    
    
    
    
48. PATEL KP, Baumbach A
    Clinical implications of sex-related differences in severe aortic stenosis.
    Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093.
    PubMed    
    
    
    
49. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
    Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
    Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
50. LONG A, Finer J, Hartman H, Hartzel D, et al
    Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
    Eur Heart J. 2025 Mar 29:ehaf248. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. CHEN M, Michel J, Kasel AM
    26 mm SAPIEN fractured 23 mm SAPIEN and surgical prosthesis: a transcatheter aortic valve-in-valve-in-valve implantation.
    Eur Heart J. 2025 Mar 29:ehaf173. doi: 10.1093.
    PubMed    
    
    
    
52. INDOLFI C, Esposito G, Luscher TF
    TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation.
    Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093.
    PubMed    
    
    
    February 2025
53. MOCUMBI A
    European Society of Cardiology guidelines for the management of valvular heart disease: should we apply these to rheumatic heart disease?
    Eur Heart J. 2025 Feb 28:ehae641. doi: 10.1093.
    PubMed    
    
    
    
54. UNGER P, Galloo X, Pibarot P
    Mixed valvular heart disease: diagnosis and management.
    Eur Heart J. 2025 Feb 27:ehaf116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    The Year in Cardiovascular Medicine 2024: the top 10 papers in valvular heart disease.
    Eur Heart J. 2025 Feb 27:ehaf071. doi: 10.1093.
    PubMed    
    
    
    
56. PEDICINO D, Vergallo R
    Weekly Journal Scan: is transcatheter replacement therapy for tricuspid regurgitation ready for prime time?
    Eur Heart J. 2025 Feb 19:ehaf060. doi: 10.1093.
    PubMed    
    
    
    
57. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
    Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
    Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
    Current status of aortic valve repair surgery.
    Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe aortic valve stenosis and obstructive coronary artery disease.
    Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093.
    PubMed    
    
    
    
60. CREA F
    Focus on aortic stenosis prevention and mitral regurgitation diagnosis.
    Eur Heart J. 2025;46:595-597.
    PubMed    
    
    
    
61. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. ANGELLOTTI D, Praz F, Windecker S
    Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay.
    Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093.
    PubMed    
    
    
    January 2025
63. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
    Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. LURZ P, Zancanaro E, Kresoja KP
    Personalized management of tricuspid valve regurgitation.
    Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093.
    PubMed    
    
    
    
65. AARTS HM, Voskuil M, Delewi R
    Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
    Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
    PubMed    
    
    
    December 2024
66. ANG DTY, Lindsay MM
    Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093.
    PubMed    
    
    
    
67. GARCIA-PAVIA P, Oreziak A, Masri A, Barriales-Villa R, et al
    Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2024;45:5071-5083.
    PubMed     Abstract available
    
    
    
68. VERGALLO R, Pedicino D
    Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve implantation in asymptomatic patients with severe aortic stenosis.
    Eur Heart J. 2024 Dec 11:ehae839. doi: 10.1093.
    PubMed    
    
    
    
69. SUN Y, Wang Z, Qian Y
    What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
    Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
    PubMed    
    
    
    
70. NASER JA, Siontis KC, Nkomo VT
    The steps towards understanding tricuspid regurgitation: one 'careful' step at a time and many more 'careful' steps needed.
    Eur Heart J. 2024 Dec 4:ehae816. doi: 10.1093.
    PubMed    
    
    
    
71. HALLE M, Wernhart S, Krane M
    Exercise in primary, secondary and tertiary prevention of aortic stenosis.
    Eur Heart J. 2024 Dec 4:ehae627. doi: 10.1093.
    PubMed    
    
    
    
72. BLASER MC, Back M, Luscher TF, Aikawa E, et al
    Calcific aortic stenosis: omics-based target discovery and therapy development.
    Eur Heart J. 2024 Dec 4:ehae829. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
73. GARG P, Pavon AG, Penicka M, Uretsky S, et al
    Cardiovascular magnetic resonance imaging in mitral valve disease.
    Eur Heart J. 2024 Nov 20:ehae801. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. LI Z, Xiang D, Hu K
    Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
    Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
    PubMed    
    
    
    
75. VERGALLO R, Pedicino D
    Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?
    Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093.
    PubMed    
    
    
    
76. COATS CJ, Masri A, Barriales-Villa R, Abraham TP, et al
    Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
    Eur Heart J. 2024;45:4464-4478.
    PubMed     Abstract available
    
    
    
77. CREA F
    Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, and acute heart failure.
    Eur Heart J. 2024;45:4451-4455.
    PubMed    
    
    
    October 2024
78. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
    Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
    Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. PEDICINO D, Vergallo R
    Weekly Journal Scan: RESHAPing potential treatment indications for functional mitral regurgitation in heart failure.
    Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093.
    PubMed    
    
    
    
80. PEDICINO D, Vergallo R
    Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral regurgitation? Still climbing.
    Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093.
    PubMed    
    
    
    
81. DE CATERINA R, Ten Cate H, Pengo V
    Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging.
    Eur Heart J. 2024 Oct 8:ehae615. doi: 10.1093.
    PubMed    
    
    
    
82. LANCELLOTTI P, Go YY, Vannan MA
    Unveiling sex differences in valvular disease care and outcomes.
    Eur Heart J. 2024;45:3834-3836.
    PubMed    
    
    
    September 2024
83. TALHA KM, Metra M, Butler J
    Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation.
    Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093.
    PubMed    
    
    
    
84. SCHOFER N, Blankenberg S
    Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
    Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
    PubMed    
    
    
    
85. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    PubMed    
    
    
    
86. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    
    
    
    
87. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    PubMed    
    
    
    
88. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    PubMed    
    
    
    
89. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
90. BONAROS N, Gollmann-Tepekoylu C, Grimm M
    Tricuspid valve trilogy: between risks and timing for surgery.
    Eur Heart J. 2024 Aug 30:ehae562. doi: 10.1093.
    PubMed    
    
    
    
91. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. MASCHERBAUER J, Kammerlander A, Nitsche C, Bax J, et al
    Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
    Eur Heart J. 2024 Aug 30:ehae523. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. NOTENBOOM ML, de Keijzer AR, Veen KM, Gokalp A, et al
    Sex-related differences in the clinical course of aortic root and ascending aortic aneurysms: the DisSEXion Study.
    Eur Heart J. 2024 Aug 26:ehae525. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    PubMed    
    
    
    
95. MACH F, Miteva K
    Window of opportunity for developing effective medical intervention for calcific aortic valve disease.
    Eur Heart J. 2024 Aug 12:ehae426. doi: 10.1093.
    PubMed    
    
    
    
96. LOPES LR, Ho CY, Elliott PM
    Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.
    Eur Heart J. 2024;45:2727-2734.
    PubMed     Abstract available
    
    
    July 2024
97. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    PubMed    
    
    
    
98. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    PubMed    
    
    
    
99. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    PubMed    
    
    
    
100. CREA F
     A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
     Eur Heart J. 2024;45:2267-2270.
     PubMed    
     
     
     
101. ARSENOS P, Tsioufis K, Gatzoulis KA
     Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients.
     Eur Heart J. 2024;45:2341-2342.
     PubMed    
     
     
     
102. HUANG Y, Wang C, Zhou T, Xie F, et al
     Lumican promotes calcific aortic valve disease through H3 histone lactylation.
     Eur Heart J. 2024 Jul 8:ehae407. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. MURARU D, Badano LP
     Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
     Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
     PubMed    
     
     
     
104. JAHANYAR J, de Kerchove L, El Khoury G
     Forme fruste unicuspid aortic valves.
     Eur Heart J. 2024 Jul 3:ehae432. doi: 10.1093.
     PubMed    
     
     
     
105. THYREGOD HGH, De Backer O, Sondergaard L
     A notion of bioprosthetic aortic valve durability.
     Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
     PubMed    
     
     
     
106. LI Z, Cheng S, Guo B, Ding L, et al
     Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.
     Eur Heart J. 2024 Jul 2:ehae406. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     
108. DIMITRIADIS K, Pyrpyris N, Tsioufis K
     Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
     Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
     PubMed    
     
     
     
109. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
     Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
     Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
110. HAHN RT
     Sex-related differences in degenerative mitral regurgitation: a call to action.
     Eur Heart J. 2024 Jun 13:ehae360. doi: 10.1093.
     PubMed    
     
     
     
111. ZHUANG Y, Wang W, Lu F
     Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
     Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
     PubMed    
     
     
     
112. CREA F
     Optimizing the treatment of severe aortic stenosis.
     Eur Heart J. 2024;45:1861-1865.
     PubMed    
     
     
     
113. VERGALLO R, Pedicino D
     Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
     Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
     PubMed    
     
     
     May 2024
114. ELTCHANINOFF H, Durand E
     Transfemoral aortic valve implantation and concomitant CAD: the jury is out.
     Eur Heart J. 2024 May 31:ehae141. doi: 10.1093.
     PubMed    
     
     
     
115. WANG J, Chen X, Zhao S
     Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
     Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
     PubMed    
     
     
     
116. 
     Correction to: Severe aortic stenosis: secular trends of incidence and outcomes.
     Eur Heart J. 2024 May 27:ehae144. doi: 10.1093.
     PubMed    
     
     
     
117. AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al
     Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes.
     Eur Heart J. 2024 May 16:ehae265. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
     Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
     Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
     Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
     Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. ZEPPENFELD K, de Riva M
     Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
     Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
     PubMed    
     
     
     April 2024
122. PIBAROT P
     Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
     Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
     PubMed    
     
     
     
123. PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al
     Anderson-Fabry disease management: role of the cardiologist.
     Eur Heart J. 2024;45:1395-1409.
     PubMed     Abstract available
     
     
     
124. KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al
     Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
     Eur Heart J. 2024;45:1443-1454.
     PubMed     Abstract available
     
     
     
125. TAHARA N, Fukumoto Y, Tayama E
     Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy.
     Eur Heart J. 2024;45:1488.
     PubMed    
     
     
     
126. BLEIZIFFER S
     Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
     Eur Heart J. 2024;45:1125-1126.
     PubMed    
     
     
     March 2024
127. FRANK D, Durand E, Lauck S, Muir DF, et al
     A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
     Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. 
     Correction to: Tricuspid valve disease and cardiac implantable electronic devices.
     Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093.
     PubMed    
     
     
     
129. BAKAR SN, Ong G, Fam NP
     LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
     Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
     PubMed    
     
     
     
130. 
     Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
     Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
     PubMed    
     
     
     
131. CREA F
     Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
     Eur Heart J. 2024;45:857-860.
     PubMed    
     
     
     
132. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
     Great debate: symptomatic moderate aortic stenosis should undergo intervention.
     Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
     PubMed    
     
     
     
133. MARTINSSON A, Rasalingam R, Jeppsson A
     Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
     Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
     PubMed    
     
     
     
134. SUDO K, Nakamura K, Sato A
     Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
     Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
     PubMed    
     
     
     
135. MURARU D, Badano LP, Hahn RT, Lang RM, et al
     Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
     Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. MEHILLI J
     Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
     Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
     PubMed    
     
     
     
137. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
     Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
     Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. MCGREGOR M, Bews H, Jassal DS
     Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
     Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
     PubMed    
     
     
     
139. MAISANO F, Hahn R, Sorajja P, Praz F, et al
     Transcatheter treatment of the tricuspid valve: current status and perspectives.
     Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
140. WU J, Zafar MA, Elefteriades JA
     Decision-making in aortic disease.
     Eur Heart J. 2024;45:633-634.
     PubMed    
     
     
     
141. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
     The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
     Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
     PubMed    
     
     
     
142. LURZ P, Kresoja KP
     Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
     Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
     PubMed    
     
     
     
143. LUDWIG S, Granada JF
     Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
     Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
     PubMed    
     
     
     
144. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. CREA F
     The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
     Eur Heart J. 2024;45:317-320.
     PubMed    
     
     
     January 2024
146. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
     Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
     Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
     PubMed    
     
     
     
147. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
     Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
     Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
     Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
     Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
     PubMed     Abstract available
     
     
     
150. NAKAMURA K, Taniguchi T, Furukawa Y
     Haemolytic anaemia after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
     PubMed    
     
     
     
151. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     
152. LONG X, Deng S, Liu W, Bu J, et al
     Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
     Eur Heart J. 2024;45:233-235.
     PubMed    
     
     
     
153. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
     Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
     Eur Heart J. 2024;45:198-210.
     PubMed     Abstract available
     
     
     
154. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
     Severe aortic stenosis: secular trends of incidence and outcomes.
     Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. KADDOURA R, Al-Hijji M
     The evolution of transcatheter valvular interventions: current evidence.
     Eur Heart J. 2024;45:10-14.
     PubMed    
     
     
     December 2023
156. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
     Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:5146-5158.
     PubMed     Abstract available
     
     
     
157. INGLES J, MacArthur DG
     The moral and practical urgency of increasing diversity in genomics.
     Eur Heart J. 2023;44:5157-5159.
     PubMed    
     
     
     
158. ANDREAS M, Burri H, Praz F, Soliman O, et al
     Tricuspid valve disease and cardiac implantable electronic devices.
     Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
     PubMed     Abstract available
     
     
     
159. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     
160. GRANI C
     Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:4793-4795.
     PubMed    
     
     
     
161. WANG J, Yang S, Ma X, Zhao K, et al
     Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
     Eur Heart J. 2023;44:4781-4792.
     PubMed     Abstract available
     
     
     November 2023
162. VERGALLO R, Volpe M
     Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
     Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
     PubMed    
     
     
     
163. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
164. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
     Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:4622-4633.
     PubMed     Abstract available
     
     
     
165. TOMII D, Praz F, Windecker S
     Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
     Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
     PubMed    
     
     
     
166. CREA F
     Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
     Eur Heart J. 2023;44:4493-4496.
     PubMed    
     
     
     
167. PATEL KP, Baumbach A
     Timing treatment for tricuspid regurgitation.
     Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
     PubMed    
     
     
     
168. WERT L, Falk V, Potapov EV
     Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
     Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
     PubMed    
     
     
     
169. IDHREES M, Kumar A, Velayudhan B
     'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
     Eur Heart J. 2023;44:4392.
     PubMed    
     
     
     
170. KODALI S, Hahn RT, Makkar R, Makar M, et al
     Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
     Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2023
171. HARARI E, Landes U
     Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
     Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
     PubMed    
     
     
     
172. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
     Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
     Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
     PubMed    
     
     
     
173. DE BACKER J, Prakash SK
     Refining the course: long-term outcome in patients with bicuspid aortic valve.
     Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
     PubMed    
     
     
     
174. FARJAT-PASOS JI, Dumont E, Paradis JM
     Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
     Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
     PubMed    
     
     
     
175. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
     Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
     Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
     PubMed     Abstract available
     
     
     
176. WEISSLER-SNIR A, Rakowski H, Meyer M
     Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
     Eur Heart J. 2023;44:3655-3657.
     PubMed    
     
     
     
177. DEVRIES JH, Irs A, Hillege HL
     The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
     Eur Heart J. 2023;44:3492-3494.
     PubMed    
     
     
     September 2023
178. CHHABRA ST, Takkar A, Arya RC
     An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
     Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
     PubMed    
     
     
     
179. BEYGUI F, Guillemot V, Saloux E
     Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
     Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
     PubMed    
     
     
     
180. MOORE JP, Aboulhosn JA, Khairy P
     Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
     Eur Heart J. 2023;44:3228-3230.
     PubMed    
     
     
     
181. CREA F
     TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
     Eur Heart J. 2023;44:3105-3109.
     PubMed    
     
     
     
182. FENG S, Wu F, Pan X
     Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
     Eur Heart J. 2023;44:3199.
     PubMed    
     
     
     August 2023
183. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
     Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
     Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
     TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
     Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
     Bicuspid aortic valve: long-term morbidity and mortality.
     Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
     PubMed     Abstract available
     
     
     
186. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
     Severe aortic stenosis detection by deep learning applied to echocardiography.
     Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
     End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
     Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
     PubMed     Abstract available
     
     
     
188. PRENDERGAST BD, Patterson T, Redwood S
     Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
     Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
     PubMed    
     
     
     
189. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
     Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
     Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. AL ZAIDI M, Nickenig G, Zimmer S
     Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
     Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
     PubMed    
     
     
     
191. EIROS R, Gallego-Delgado M, Villacorta E
     Unravelling an hypertrophic myocardiopathy.
     Eur Heart J. 2023;44:2788.
     PubMed    
     
     
     July 2023
192. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
     Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
     Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
     PubMed    
     
     
     
193. WALDSCHMIDT L, Seiffert M
     Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
     Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
     PubMed    
     
     
     
194. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
     Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
     Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
     PubMed     Abstract available
     
     
     
195. LORENZATTI D, Pina P, Slipczuk L
     Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
     Eur Heart J. 2023;44:2350.
     PubMed    
     
     
     June 2023
196. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
     Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
     Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. GOEL K, Shah P, Jones BM, Korngold E, et al
     Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
     Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. 
     Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
     PubMed    
     
     
     
199. TAKANO R, Tsuji A, Ogo T
     A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
     Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
     PubMed    
     
     
     
200. PEDICINO D, Vergallo R
     Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
     Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
     PubMed    
     
     
     
201. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
     Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
     Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. EVANGELISTA A, Michelena HI
     Family screening for bicuspid aortic valve: indicated, but easy to implement?
     Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
     PubMed    
     
     
     
203. CREA F
     Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
     Eur Heart J. 2023;44:1847-1850.
     PubMed    
     
     
     May 2023
204. LORENZINI M, Elliott PM
     Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
     Eur Heart J. 2023;44:1519-1521.
     PubMed    
     
     
     
205. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
     Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
     Eur Heart J. 2023;44:1530-1540.
     PubMed     Abstract available
     
     
     April 2023
206. BUTCHER SC, Essayagh B, Enriquez-Sarano M
     Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
     Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
     PubMed    
     
     
     
207. DANDEL M
     Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
     Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
     PubMed    
     
     
     
208. LI Y, He Q, Xie M
     A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
     Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
     PubMed    
     
     
     
209. LEE J, Kim JS, Shim CY
     MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
     PubMed    
     
     
     
210. PEDICINO D, Vergallo R
     Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
     Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
     PubMed    
     
     
     
211. ORRINGER CE
     C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
     Eur Heart J. 2023;44:1461-1463.
     PubMed    
     
     
     
212. THERIAULT S, Mathieu P, Bosse Y
     The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
     Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
     PubMed    
     
     
     
213. CHEN HY, Dina C, Small AM, Shaffer CM, et al
     Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
     Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
     PubMed     Abstract available
     
     
     
214. SEQUEIRA V, Batzner A, Maack C
     Targeting mitochondria in hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:1186-1188.
     PubMed    
     
     
     
215. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
     Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
     Eur Heart J. 2023;44:1170-1185.
     PubMed     Abstract available
     
     
     March 2023
216. KAGASE A, Yamamoto M, Tokuda T
     Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
     Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
     PubMed    
     
     
     
217. XIE Z, Zhu H
     A rare case of mitral regurgitation caused by primary aldosteronism.
     Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
     PubMed    
     
     
     
218. CHEN YH, Chang HH, Leu HB
     Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
     Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
     PubMed    
     
     
     
219. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
     Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
     Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. CHORIN E, Topilsky Y
     The synergy between tricuspid regurgitation and machine learning.
     Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
     PubMed    
     
     
     
221. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
     Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
     Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
     Unmet needs in valvular heart disease.
     Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. CHUNG CJ, Otto CM
     Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
     Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
     PubMed    
     
     
     
224. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
     Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
     Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
     PubMed     Abstract available
     
     
     
225. CREA F
     Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
     Eur Heart J. 2023;44:783-787.
     PubMed    
     
     
     
226. RODES-CABAU J, Nuche J
     Are contemporary TAVI results influenced by hospital volume?
     Eur Heart J. 2023;44:868-870.
     PubMed    
     
     
     
227. CHEN J, Yang Y, Wei L
     One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
     Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
     PubMed    
     
     
     
228. KEMALOGLU OZ T, Badano LP
     Can three-dimensional echocardiography change the game for the pulmonary valve?
     Eur Heart J. 2023;44:703-705.
     PubMed    
     
     
     October 2021
229. ELLIOTT P
     Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
     Eur Heart J. 2021;42:3945-3947.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.